Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subotheni Thavaneswaran

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Expert Review of Anticancer Therapy|December 15, 2015
Optimal therapy for resectable rectal cancerSubotheni Thavaneswaran, Timothy J Price
Expert Review of Anticancer Therapy|August 19, 2017
Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysisSubotheni Thavaneswaran, Peey Sei Kok, Timothy Price
Current Oncology (Toronto, Ont.)|March 26, 2025
Contemporary Patterns of Care for Low-Grade Glioma in Australia and New ZealandMeghana Maddula, Nicholas McNamee, Hui K Gan, et al.
JCO Precision Oncology|December 1, 2022
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an <i>NRG1</i> FusionSubotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, et al.
Oncotarget|October 22, 2021
The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide surveySubotheni Thavaneswaran, Mandy Ballinger, Phyllis Butow, et al.
Nature Reviews. Clinical Oncology|April 19, 2019
Author Correction: Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Nature Reviews. Clinical Oncology|February 21, 2019
Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Cancer Medicine|April 27, 2026
A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid TumoursAijia Meng, Alexander Yuile, Hao-Wen Sim, et al.
Surgery|October 18, 2024
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) programElan Novis, Anthony Glover, John P Grady, et al.
Studies in Health Technology and Informatics|August 8, 2025
Automating Precision Oncology Literature Curation: A Decision Tree Approach Using Large Language ModelsFrank P Lin, Minh Tran, Subotheni Thavaneswaran, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Expert Review of Anticancer Therapy|December 15, 2015
Optimal therapy for resectable rectal cancerSubotheni Thavaneswaran, Timothy J Price
Expert Review of Anticancer Therapy|August 19, 2017
Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysisSubotheni Thavaneswaran, Peey Sei Kok, Timothy Price
Current Oncology (Toronto, Ont.)|March 26, 2025
Contemporary Patterns of Care for Low-Grade Glioma in Australia and New ZealandMeghana Maddula, Nicholas McNamee, Hui K Gan, et al.
JCO Precision Oncology|December 1, 2022
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an <i>NRG1</i> FusionSubotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, et al.
Oncotarget|October 22, 2021
The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide surveySubotheni Thavaneswaran, Mandy Ballinger, Phyllis Butow, et al.
Nature Reviews. Clinical Oncology|April 19, 2019
Author Correction: Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Nature Reviews. Clinical Oncology|February 21, 2019
Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Cancer Medicine|April 27, 2026
A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid TumoursAijia Meng, Alexander Yuile, Hao-Wen Sim, et al.
Surgery|October 18, 2024
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) programElan Novis, Anthony Glover, John P Grady, et al.
Studies in Health Technology and Informatics|August 8, 2025
Automating Precision Oncology Literature Curation: A Decision Tree Approach Using Large Language ModelsFrank P Lin, Minh Tran, Subotheni Thavaneswaran, et al.
Pageof 4